Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Cauble Jeffery

2. Date of Event Requiring Statement (MM/DD/YYYY) 3/10/2017

3. Issuer Name and Ticker or Trading Symbol

CESCA THERAPEUTICS INC. [KOOL]

(Last) (First) (Middle)

2711 CITRUS ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Principal Accounting Officer /

(Street)

RANCHO CORDOVA, CA 95742

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock (Restricted) ⁽³⁾	90	D
Common Stock (Restricted) ⁽²⁾	833	D
Common Stock (Restricted) ⁽¹⁾	9230	D
Common Stock	2446	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options	⁽⁴⁾	7/1/2018	Common Stock	188	$27.4000	D
Stock Options	⁽⁵⁾	9/10/2022	Common Stock	1250	$12.6000	D
Stock Options	⁽⁶⁾	7/7/2023	Common Stock	4000	$2.8600	D

Explanation of Responses:
( 1)	Represents 9,230 shares of restricted stock that vest 100% on July 1, 2017 on the condition that participant continues to be employed at vesting date or sooner if terminated.
( 2)	Half vests on May 5, 2017 and the remainder on May 5, 2018.
( 3)	Vests on June 30, 2017.
( 4)	141 of the 188 options are currently vested with the remainder vesting on July 1, 2017.
( 5)	626 options are currently vested. The remaining 624 vests in thirds on September 10, 2017, March 10, 2018 and September 10, 2018.
( 6)	Options vest every 6 months over a 3 year period starting January 7, 2017.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Cauble Jeffery 2711 CITRUS ROAD RANCHO CORDOVA, CA 95742			Principal Accounting Officer

Signatures
/s/ Jeffery Cauble		3/15/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.